Related Experiment Video
Updated: Oct 14, 2025

Using Reference Reagents to Confirm Robustness of Cytokine Release Assays for the Prediction of Monoclonal Antibody Safety
Published on: September 15, 2023
A summertime pause in immunoglobulin replacement therapy: a prospective real-world analysis
Victor Hémar1, Etienne Rivière1,2, Carine Greib1
1Department of Internal Medicine & Infectious Diseases, Bordeaux Hospital University, Avenue de Magellan, Pessac, 33604, France.
Abstract:
Aim: To describe the effects of a summertime pause (SP) in immunoglobulin replacement therapy (IgRT). Patients & methods: We conducted a prospective single-center observational study, including 44 patients undergoing intravenous IgRT between May and June 2019 in a French teaching hospital. Results: IgRT was interrupted in 23 patients from June to October. Patients who underwent an SP were older, more likely to have secondary immunodeficiency (SID) and received lower doses of immunoglobulin and more antibiotics during winter. Most patients who did not undergo an SP had severe primary immunodeficiency. The SP did not increase the risk of infection, improved the quality of life and reduced treatment costs. Conclusion: SP in IgRT is a safe practice and should be considered for patients with mild SID.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

